ONE SIX 8 VENTURES
  • Home
  • About
  • Entrepreneur
  • Contact

Solving Critical Global Healthcare Challenges Through Focused MedTech Investing


About

One Six 8 Ventures is a venture capital firm partnering with exceptional entrepreneurs to build transformative early-stage MedTech companies. Our core mission is to back innovations that fundamentally improve patient outcomes while creating substantial market value.

Our investment focus is clear: early-stage Medical Technology. We maintain a disciplined approach, targeting specific sub-sectors where innovation can drive significant clinical and market impact.

​Built over nearly two decades, our team offers a distinct advantage: direct experience as founders, operators, and executives within VC-backed MedTech and life sciences. This allows us to conduct deep, multi-faceted due diligence and actively partner with founders post-investment. We provide hands-on strategic and operational guidance, leveraging our experience to help companies navigate growth, manage risk effectively, preserve capital, and achieve market leadership.​

THE TEAM

The One Six 8 Ventures team comprises seasoned operators and executives with deep roots in scaling VC-backed life sciences companies over nearly two decades. We act as hands-on partners to our portfolio founders, providing strategic guidance and support grounded in extensive industry experience. Learn more about our team below:
Picture

Judyanna Yu, CPA, CA

Managing Partner
CFO, Providence Therapeutics
CFO & COO, Restem Biotech 

CFO, Biochem Group
VP Corporate Finance, Cerecin
Health business entrepreneur​
​Previous: Manning Elliott LLP, KPMG, Auditor General of Alberta

Board, BioAlberta
Board, Pharmsky Research
Picture

Charles Stacey, MD, MBA

Partner
President & CEO, Cerecin

Inventages Venture Capital ($1.5B AUM)
Orthopaedics and trauma surgeon in London
Medtech entrepreneur
​Board of Governors, Accreditation Council for Medical Affairs
​
Picture

Ankang Li, PhD, JD, CFA

Advisor
CFO, CSO and Executive Director, Brii Biosciences
CEO, TSB Therapeutics
CFO, Terns Pharmaceutical
​Executive Director, Healthcare Investment Banking, 
Goldman Sachs,
BD Director, Merck,
Associate at Davis Polk, Ropes & Gray
Picture

Xi Qiao, MSc

Principal
Head of BD Commercial Evaluation, Fosun Pharma,
Consultant at Boston Consulting Group,
Pricing and Market Access Manager, AstraZeneca,
​Health & TMT Senior Consultant, Ernst & Young  

ADVISORS

Alden Aumann, CPA, CA

Picture

• Managing Partner, Manning Elliott LLP
• Serial entrepreneur and investor
• Private wealth firm founder
• ​Leader and mentor for SMEs

Neeraj Gupta

Picture

• Serial entrepreneur, angel investor, board member for startups/ NPO
• Co-founder of Lawcubator and FormulateIP, and Chief Advisor for Technology & Innovation at Invest Alberta
• Board member of Platform Calgary, Canadian Blockchain Consortium, Calgary Chambers, and TIDES
• Author of “Creating and Safeguarding a Strong Intellectual Property Portfolio”

​Jaspreet ​Grewal, MBA, MSc, CCRP

Picture

• Leader in clinical medicine, research and regulatory affairs, trained in Georgetown, Yale, Harvard and LSE
• Co-founder and CEO of AxialBridge, global life sciences advisory firm
• Board Director, entrepreneur in residence, and graduate program instructor

James Topham
Picture
• BC Innovators Hall of Fame
• Former KPMG Partner, former board of BC Tech
• Founder of Vancouver Social Venture Partners philanthropy group
• ​Board member, various biotech and tech companies
​
Picture
At One Six 8 Ventures, we are dedicated partners in the pursuit of innovation and growth within the Health and Life Science industry. Our passion for impactful investing drives us to see endless possibilities for transformative change.

​
Contact Us

    Subscribe to our mailing list

Subscribe to Newsletter


​


​

  • Home
  • About
  • Entrepreneur
  • Contact